GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » 4DMedical Ltd (ASX:4DX) » Definitions » Beneish M-Score

4DMedical (ASX:4DX) Beneish M-Score : 8.96 (As of Mar. 30, 2025)


View and export this data going back to 2020. Start your Free Trial

What is 4DMedical Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score 8.96 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for 4DMedical's Beneish M-Score or its related term are showing as below:

ASX:4DX' s Beneish M-Score Range Over the Past 10 Years
Min: -5.15   Med: 1.91   Max: 8.96
Current: 8.96

During the past 4 years, the highest Beneish M-Score of 4DMedical was 8.96. The lowest was -5.15. And the median was 1.91.


4DMedical Beneish M-Score Historical Data

The historical data trend for 4DMedical's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4DMedical Beneish M-Score Chart

4DMedical Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Beneish M-Score
- - -5.15 8.96

4DMedical Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only - -5.15 - 8.96 -

Competitive Comparison of 4DMedical's Beneish M-Score

For the Medical Devices subindustry, 4DMedical's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


4DMedical's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, 4DMedical's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where 4DMedical's Beneish M-Score falls into.


;
;

4DMedical Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of 4DMedical for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.161+0.528 * 0.9535+0.404 * 10.7521+0.892 * 10.8156+0.115 * 0.7129
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.1111+4.679 * -0.121745-0.327 * 1.0427
=8.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun24) TTM:Last Year (Jun23) TTM:
Total Receivables was A$1.42 Mil.
Revenue was A$3.05 Mil.
Gross Profit was A$2.81 Mil.
Total Current Assets was A$40.20 Mil.
Total Assets was A$121.71 Mil.
Property, Plant and Equipment(Net PPE) was A$9.29 Mil.
Depreciation, Depletion and Amortization(DDA) was A$4.07 Mil.
Selling, General, & Admin. Expense(SGA) was A$30.17 Mil.
Total Current Liabilities was A$24.88 Mil.
Long-Term Debt & Capital Lease Obligation was A$4.18 Mil.
Net Income was A$-35.98 Mil.
Gross Profit was A$9.71 Mil.
Cash Flow from Operations was A$-30.87 Mil.
Total Receivables was A$0.82 Mil.
Revenue was A$0.28 Mil.
Gross Profit was A$0.25 Mil.
Total Current Assets was A$78.54 Mil.
Total Assets was A$92.92 Mil.
Property, Plant and Equipment(Net PPE) was A$9.26 Mil.
Depreciation, Depletion and Amortization(DDA) was A$2.57 Mil.
Selling, General, & Admin. Expense(SGA) was A$25.11 Mil.
Total Current Liabilities was A$17.07 Mil.
Long-Term Debt & Capital Lease Obligation was A$4.21 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1.419 / 3.05) / (0.815 / 0.282)
=0.465246 / 2.890071
=0.161

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(0.248 / 0.282) / (2.813 / 3.05)
=0.879433 / 0.922295
=0.9535

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (40.202 + 9.292) / 121.713) / (1 - (78.539 + 9.257) / 92.924)
=0.593355 / 0.055185
=10.7521

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=3.05 / 0.282
=10.8156

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(2.565 / (2.565 + 9.257)) / (4.065 / (4.065 + 9.292))
=0.216968 / 0.304335
=0.7129

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(30.167 / 3.05) / (25.112 / 0.282)
=9.89082 / 89.049645
=0.1111

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((4.176 + 24.884) / 121.713) / ((4.206 + 17.072) / 92.924)
=0.238758 / 0.228983
=1.0427

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-35.979 - 9.706 - -30.867) / 121.713
=-0.121745

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

4DMedical has a M-score of 8.96 signals that the company is likely to be a manipulator.


4DMedical Beneish M-Score Related Terms

Thank you for viewing the detailed overview of 4DMedical's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


4DMedical Business Description

Traded in Other Exchanges
N/A
Address
700 Swanston Street, Level 7, Melbourne Connect, Carlton, VIC, AUS, 3053
4DMedical Ltd is a company focused on medical research technology and the development of a non-invasive respiratory imaging solution using four-dimensional imaging. The four-dimensional lung imaging technology utilizes mathematical models and algorithms to convert X-ray scans into quantitative data, aiding physicians in managing patients with respiratory and lung diseases.

4DMedical Headlines

No Headlines